The downgrade from Buy to Neutral and the significant reduction in the price target from $8 to $3 by Roth MKM analyst Darren Aftahi indicate a less optimistic outlook for Veritone. This could negatively impact the stock price in the short term as investors may adjust their positions based on the new rating and price target.